Xconomy: BioBeat News, Articles and Opinions

“biobeat” Archives

Entry	Author	Date	Location
Farewell, Xconomy Readers. I’m Going to Climb a New Mountain	Luke Timmerman	03/05/14	National
PacBio, the Post-Hype Sleeper of Genomics	Luke Timmerman	03/03/14	National
Hiring in Biotech is Tricky. But Algorithms Won’t Save the Day	Luke Timmerman	02/24/14	National
San Diego Life Sciences Roundup: Lithera, CardioCell, and More	Bruce V. Bigelow	02/21/14	San Diego
Molecular Diagnostics Are in a Rut. The Industry Needs the FDA	Luke Timmerman	02/17/14	National
The Young and Proven Biotech VCs From 2012. Where Are They Now?	Luke Timmerman	02/10/14	National
The $1K Genome? So What? Illumina Is On a Quest for World Domination	Luke Timmerman	02/03/14	National
Gene Therapy Lurches Ahead, Sees Thorny Future Questions on Price	Luke Timmerman	01/27/14	National
The Big Guys Have Lost Their Iron Grip, and It’s All Good	Luke Timmerman	01/20/14	National
What Biotech Pros Will Be Chirping About at JP Morgan This Week	Luke Timmerman	01/13/14	National
Josh Boger Finds Beauty Off the Coast of Fiji, in Life After Vertex	Luke Timmerman	01/06/14	National
10 Tips for Maximizing the JP Morgan Healthcare Experience	Luke Timmerman	12/23/13	National
What Was Hyped, and What Fell Out of Favor, This Year in Biotech	Luke Timmerman	12/16/13	National
12 Things the Pharma Industry Can Do to Rebuild Real Public Trust	Luke Timmerman	12/09/13	National
3 Life Sciences Companies That Are Built to Last	Luke Timmerman	12/02/13	National
Gates Foundation Health Chief on Coaxing Pharma to Do Good (Part 2)	Luke Timmerman	11/26/13	National
Gates Foundation Health Chief on Coaxing Pharma to Do Good	Luke Timmerman	11/25/13	National
The Biotech Startup Class of 2013: Don’t Worry, It’s a Short List	Luke Timmerman	11/18/13	National
How Alkermes Survived a Brush With Death	Luke Timmerman	11/11/13	National
Which Regions Are Churning Out the Most Biotech IPOs?	Luke Timmerman	11/04/13	National
The Biggest Bargains Pharma Scooped Up in the Down Years	Luke Timmerman	10/28/13	National
21 Red Flags to Watch for in a Biotech Company	Luke Timmerman	10/21/13	National
The $100M Club: Where the Major League Life Sciences Companies Are	Luke Timmerman	10/14/13	National
Harvard’s Verdine Blazing Trail for Scientific Entrepreneurs	Luke Timmerman	10/07/13	National
The Pharma Bureaucracy Index: Who’s Nimble, and Who’s Sloooowww?	Luke Timmerman	09/30/13	National
The Best Biotech Graduate Schools in Real Life	Luke Timmerman	09/23/13	National
Don’t Be Naïve: 7 Things to Know Before Taking a Biotech Startup Job	Luke Timmerman	09/16/13	National
Which VCs Are Poised to Profit From the Biotech IPO Boom?	Luke Timmerman	09/09/13	National
Biotech and Fantasy Football Picks for Fall 2013	Luke Timmerman	09/03/13	National
Why Good Drugs Sometimes Fail: The Bexxar Story	Luke Timmerman	08/26/13	National
Page 1 of 6	next page »